文献速递创伤与烧伤复苏、休克与脓毒症

冒充者还是闪亮盔甲骑士?骨盆环周加压装置(PCCD)用于多发伤患者严重骨盆损伤:一项创伤登记分析

Imposter or knight in shining armor? Pelvic circumferential compression devices (PCCD) for severe pelvic injuries in patients with multiple trauma: a trauma-registry analysis.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2024-01-16
一句话结论在德国创伤登记中,院前使用PCCD与骨盆环不稳定骨折患者的死亡率或输血需求无显著改善相关,且存在过度使用与使用不足并存。

该回顾性队列研究基于德国创伤学会创伤登记(TR-DGU)2016至2021年63,371例成人严重创伤患者,分析院前骨盆环周加压装置(PCCD)使用趋势,并按倾向性评分匹配比较多发伤合并骨盆环不稳定骨折(UPF)患者院前使用与未使用PCCD的结局。结果显示UPF发生率为9%(N=5880),PCCD使用率从7.5%升至20.4%;UPF患者中40.2%接受了PCCD,而所有使用PCCD的病例中61%并无骨盆损伤。PCCD组24小时死亡率更高(10.9% vs 9.3%,p=0.033),院内死亡率有升高趋势(17.9% vs 16.1%,p=0.070),院内死亡率较预测低1%,标准化死亡率比(SMR)有利于PCCD但未达统计学显著(0.95 vs 1.04,p=0.101)。匹配后1,860对分析显示,无PCCD组更常使用儿茶酚胺(19.6% vs 18.5%,p=0.043)但急诊室骨盆手术稳定需求更少(28.6% vs 36.8%,p<0.001),两组死亡率和输血需求无差异。作者认为PCCD更多是损伤严重度的标志而非由UPF触发,未发现生存或输血获益,适应症不当和技术缺陷可能使结果产生偏倚,呼吁开展前瞻性试验。

要点

  • UPF患者中仅40.2%接受了PCCD,而所有PCCD使用病例中61%并无骨盆损伤,提示适应症选择存在过度与不足。
  • PCCD组24小时死亡率更高(10.9% vs 9.3%,p=0.033),院内死亡率有升高趋势(17.9% vs 16.1%,p=0.070),但院内死亡率较预测低1%。
  • SMR有利于PCCD但未达统计学显著(0.95 vs 1.04,p=0.101)。
  • 倾向性评分匹配后1,860对分析:无PCCD组更常使用儿茶酚胺(19.6% vs 18.5%,p=0.043),但急诊室骨盆手术稳定需求更少(28.6% vs 36.8%,p<0.001)。
  • 匹配后两组死亡率和输血需求无差异,院前PCCD似乎是损伤严重度的标志而非UPF的特异性治疗。

适用人群与场景

  • 2016年至2021年纳入德国创伤学会创伤登记(TR-DGU)的63,371例成人严重创伤患者。
  • 分析对象为多发伤合并骨盆环不稳定骨折(UPF)的患者,比较院前接受PCCD与未接受PCCD者。

研究设计与关键结果

  • 研究类型:回顾性队列研究,基于德国创伤学会创伤登记(TR-DGU),2016年至2021年纳入63,371例成人严重创伤患者。
  • UPF总发生率为9%(N=5880),PCCD使用率从7.5%上升至20.4%。
  • UPF患者中40.2%接受了PCCD;所有使用PCCD的病例中61%无骨盆损伤。
  • PCCD组损伤更严重,休克或输血率更高;24小时死亡率PCCD组10.9% vs 无PCCD组9.3%(p=0.033),院内死亡率17.9% vs 16.1%(p=0.070)。
  • PCCD组院内死亡率较预测低1%;SMR 0.95 vs 1.04(p=0.101),有利于PCCD但未达统计学显著。
  • 倾向性评分匹配1,860对:无PCCD组更常使用儿茶酚胺(19.6% vs 18.5%,p=0.043),但急诊室骨盆手术稳定需求更少(28.6% vs 36.8%,p<0.001);两组死亡率和输血需求无差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(创伤登记分析)。
  • 局限:TR-DGU不包含PCCD适应症和技术缺陷的数据;适应症不当和技术缺陷可能使结果产生偏倚;作者认为需要进一步研究,并强烈建议开展前瞻性试验。

对床旁实践的改变

  • 作者认为院前PCCD似乎是损伤严重度的标志,而非由UPF触发;未发现对生存或输血需求的获益。
  • 作者认为适应症不当和技术缺陷可能使结果产生偏倚,并担心PCCD的使用可能因对现有证据的误读而受到不公平的质疑。
  • 作者强烈建议开展前瞻性试验;登记系统附加模块化问卷可能是克服该局限的一种方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pelvic Circumferential Compression Devices (PCCD) are standard in hemorrhage-control of unstable pelvic ring fractures (UPF). Controversial data on their usefulness exists. Aim of the study was to investigate whether prehospital application of PCCD can reduce mortality and transfusion requirements in UPF.

METHODS: Retrospective cohort study. From 2016 until 2021, 63,371 adult severely injured patients were included into TraumaRegister DGU® of the German Trauma Society (TR-DGU). We analyzed PCCD use over time and compared patients with multiple trauma patients and UPF, who received prehospital PCCD to those who did not (noPCCD). Groups were adjusted for risk of prehospital PCCD application by propensity score matching. Primary endpoints were hospital mortality, standardized mortality rate (SMR) and transfusion requirements.

RESULTS: Overall UPF incidence was 9% (N = 5880) and PCCD use increased over time (7.5% to 20.4%). Of all cases with UPF, 40.2% received PCCD and of all cases with PCCD application, 61% had no pelvic injury at all. PCCD patients were more severely injured and had higher rates of shock or transfusion. 24-h.-mortality and hospital mortality were higher with PCCD (10.9% vs. 9.3%; p = 0.033; 17.9% vs. 16.1%, p = 0.070). Hospital mortality with PCCD was 1% lower than predicted. SMR was in favor of PCCD but failed statistical significance (0.95 vs. 1.04, p = 0.101). 1,860 propensity score matched pairs were analyzed: NoPCCD-patients received more often catecholamines (19.6% vs. 18.5%, p = 0.043) but required less surgical pelvic stabilization in the emergency room (28.6% vs. 36.8%, p < 0.001). There was no difference in mortality or transfusion requirements.

CONCLUSION: We observed PCCD overuse in general and underuse in UPF. Prehospital PCCD appears to be more a marker of injury severity and less triggered by presence of UPF. We found no salutary effect on survival or transfusion requirements. Inappropriate indication and technical flaw may have biased our results. TR-DGU does not contain data on these aspects. Further studies are necessary. Modular add-on questioners to the registry could offer one possible solution to overcome this limitation. We are concerned that PCCD use may be unfairly discredited by misinterpretation of the available evidence and strongly vote for a prospective trial.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Trentzsch H, Lefering R, Schweigkofler U, et al. Imposter or knight in shining armor? Pelvic circumferential compression devices (PCCD) for severe pelvic injuries in patients with multiple trauma: a trauma-registry analysis. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38225602. doi:10.1186/s13049-023-01172-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。